Clinical Trial

Trial Protocol ID USOR 22123_1403-0011_Brightline-2 *STAR*

Trial Description

A Phase IIa/IIb, open-label, single-arm, multi-centre trial of brigimadlin (BI 907828) for treatment of patients with locally advanced/ metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Sponsor

  • BOEHRINGER INGELHEIM

ClinicalTrials.gov NCT ID

  • NCT05512377